Genetic Screening: From Newborns to DNA Typing : Proceedings of the Workshop on Genetic Screening Held at La Sapinière, Québec (Canada) 13th-14th October 1989 for the Bi-annual Meeting Between the Quebec Network of Genetic Medicine and the New England Regional Screening Program, with a Special Invitation Extended to L'Association Française de Prévention Des Handicaps de L'enfantDramatic advances in recombinant DNA technology are about to bring fundamental changes in genetic screening. As clinically oriented researchers pursue dozens of disease genes, basic scientists dazzle us with new technologies, one of the most important being the polymerase chain reaction. The questions accompanying screening scenarios seem to amplify at a rate approaching that of the polymerase chain reaction. Genetic Screening: From Newborns to DNA Typing arrives at a crucial moment to help us confront these and many other questions. It is the work product of two dozen leading authorities in the field of newborn screening who gathered to focus their thoughts intensively on the present state of screening and to formulate principles to guide the practice of neonatal screening in the next decade. The book is logically organized and presents much valuable material, examines the more recent experiences in screening for congenital diseases, ascertaining HIV seroprevalence, and raises important ethical and legal questions. The volume is an admirable conception and will undoubtedly be of interest to all involved with genetic testing. |
Contents
Is that | 11 |
Organization | 41 |
Submitted papers for Session | 65 |
Copyright | |
16 other sections not shown
Common terms and phrases
addition affected AIDS analysis anonymous antibodies approach assay Association benefit birth blood blood spots carrier cell child clinical collection confidentiality congenital consent considered counseling detection determine diagnosis discussion disease disorders duty early et al ethical evaluation example fact France future gene genetic screening going haplotype HIV infection human hypothyroidism identified important individual infants infection informed consent interest involved issues Knoppers Laberge laboratory limited means measures methods mutations neonatal screening newborn screening normal obtained parents participate patients Pediatr person physician population positive possible potential present problems procedures protection public health question reason relatives reported require respect responsibility risk samples Science screening programs sequence seroprevalence specific specimens statutes studies surveillance testing treatment typing women